Matthew Robson
Research Fellow
Last active: 10/19/2015

  1. Synthesis and pharmacological evaluation of indole-based sigma receptor ligands. M├ęsangeau C, Amata E, Alsharif W, Seminerio MJ, Robson MJ, Matsumoto RR, Poupaert JH, McCurdy CR (2011) Eur J Med Chem 46(10): 5154-61
    › Primary publication · 21899931 (PubMed) · PMC3272488 (PubMed Central)
  2. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. Kaushal N, Robson MJ, Vinnakota H, Narayanan S, Avery BA, McCurdy CR, Matsumoto RR (2011) AAPS J 13(3): 336-46
    › Primary publication · 21494909 (PubMed) · PMC3160158 (PubMed Central)
  3. Sigma receptors: potential targets for a new class of antidepressant drug. Fishback JA, Robson MJ, Xu YT, Matsumoto RR (2010) Pharmacol Ther 127(3): 271-82
    › Primary publication · 20438757 (PubMed) · PMC3993947 (PubMed Central)
  4. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Gengo FM, Rainka M, Robson M, Gengo MF, Forrest A, Hourihane M, Bates V (2008) J Clin Pharmacol 48(3): 335-43
    › Primary publication · 18223144 (PubMed)
  5. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis. Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V (2008) J Clin Pharmacol 48(1): 117-22
    › Primary publication · 18094224 (PubMed)